Ceritinib (LDK378) for treatment of patients with ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC) and brain metastases (BM) in the ASCEND-1 trial Meeting Abstract
| Authors: | Shaw, A.; Mehra, R.; Tan, D. S. W.; Felip, E.; Chow, L. Q. M.; Camidge, D. R.; Vansteenkiste, J.; Sharma, S.; De Pas, T.; Riely, G. J.; Solomon, B. J.; Wolf, J.; Thomas, M.; Schuler, M.; Liu, G.; Santoro, A.; Geraldes, M.; Sen, P.; Boral, A. J.; Yovine, A.; Kim, D. W. |
| Abstract Title: | Ceritinib (LDK378) for treatment of patients with ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC) and brain metastases (BM) in the ASCEND-1 trial |
| Meeting Title: | 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 16 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2014 Nov 13-16 |
| Meeting Location: | Miami, FL |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2014-11-01 |
| Start Page: | v39 |
| Language: | English |
| ACCESSION: | WOS:000350452200150 |
| DOI: | 10.1093/neuonc/nou240.32 |
| PROVIDER: | Thomson Reuters Web of Science™ |
| PROVIDER: | wos |
| PMCID: | PMC4217934 |
| Notes: | Meeting Abstract: BM-32 -- Source: Wos |
